Traditional Chinese Medicines as Anticancer Agents for Non-Small Cell Lung Cancer with EGFR Mutations: A Review.

Drug Des Devel Ther · 2025 · PMC12182731 · PMID 40546658

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Clinically, T790M is highly significant due to its high prevalence (50–70%) in EGFR-mutant lung adenocarcinomas that progress during treatment with first- or second-generation TKIs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.